Lifeward (LFWD) Cash from Financing Activities (2015 - 2026)
Lifeward (LFWD) reported Cash from Financing Activities of $6.4 million for Q1 2026, up 43.64% on a YoY basis from $4.5 million in Q1 2025, and up 69.98% sequentially from $3.8 million in Q4 2025.
Lifeward (LFWD) Cash from Financing Activities (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 11 years of Cash from Financing Activities data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 43.64% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (up 216.57% YoY), and the FY2025 full-year result was $12.2 million, changed N/A from the prior year.
- Cash from Financing Activities climbed to $6.4 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $6.4 million in Q1 2026 to a low of -$2.3 million in Q4 2022.
- A 4-year average of $1.5 million and a median of $320000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 682.77% in 2022 and jumped 96.72% in 2023, its largest moves.
- Tracing LFWD's Cash from Financing Activities over 4 years: stood at -$2.3 million in 2022, then soared by 99.74% to -$6000.0 in 2023, then soared by 63066.67% to $3.8 million in 2025, then surged by 69.98% to $6.4 million in 2026.
- Business Quant data shows LFWD's Cash from Financing Activities at $6.4 million in Q1 2026, $3.8 million in Q4 2025, and $646000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 6.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 646,000.00 |
| Sep 30, 2025 | 646,000.00 |
| Jun 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 3.31 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Mar 31, 2025 | 4.47 Mn |
| Sep 30, 2023 | -6,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Mar 31, 2023 | -771,000.00 |
| Mar 31, 2023 | -771,000.00 |
| Dec 31, 2022 | -2.32 Mn |
| Dec 31, 2022 | -2.32 Mn |
| Sep 30, 2022 | -183,000.00 |
| Sep 30, 2022 | -183,000.00 |